Real-world associations of pathological complete response and survival with neoadjuvant pembrolizumab in early TNBC: a Turkish Oncology Group study

H Harun Muğlu E Erdem Sünger O Oğuzcan Özkan T Taha Koray Şahin B Bahadır Köylü K Kaan Helvacı Y Yasemin Kemal (Department of Medical Oncology, Faculty of Medicine, Altınbas University, Istanbul, Turkey) U Umut Demirci (Memorial Ankara Hospital, Ankara, Turkey) F Fatih Selçukbiricik G Gül Başaran B Başak Oyan Uluç O Omer Fatih Olmez S Sercan Aksoy E Erhan Gökmen A Ahmet Bilici

Article Details

Volume / Issue Vol. 16, Issue 1
Published April 03, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (15)

H

Harun Muğlu

E

Erdem Sünger

O

Oğuzcan Özkan

T

Taha Koray Şahin

B

Bahadır Köylü

K

Kaan Helvacı

Y

Yasemin Kemal

Department of Medical Oncology, Faculty of Medicine, Altınbas University, Istanbul, Turkey

U

Umut Demirci

Memorial Ankara Hospital, Ankara, Turkey

F

Fatih Selçukbiricik

G

Gül Başaran

B

Başak Oyan Uluç

O

Omer Fatih Olmez

S

Sercan Aksoy

E

Erhan Gökmen

A

Ahmet Bilici